生物活性 | |||
---|---|---|---|
描述 | Dimethylmalonate is a competitive SDH (succinate dehydrogenase) inhibitor. It led to an increase in succinate in the cytosol, presumably by impairing the oxidation of succinate to fumarate, and also boosted LPS-induced succinate accumulation. Limiting succinate oxidation by dimethylmalonate induced an anti-inflammatory response at 10mM in BMDMs. Dimethylmalonate, at dose of 160 mg/kg, i.p., also showed anti-inflammatory effect on LPS-induced sepsis mice model. It decreased serum levels of IL-1β and boosted IL-10, but had no significant effect on TNF-α, as well as reduced IL-1β and PHD3 expression in the spleen[1]. | ||
作用机制 | Dimethylmalonate is a competitive SDH inhibitor. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
7.57mL 1.51mL 0.76mL |
37.85mL 7.57mL 3.78mL |
75.69mL 15.14mL 7.57mL |
参考文献 |
---|